Teng C. Lee, MD, FACS, is an associate professor of surgery in the
Division of Adult Cardiothoracic Surgery at University of California, San
Francisco, and co-director of the UCSF Center for Aortic Disease. In addition, he is a cardiothoracic surgeon at Washington Township Medical
Foundation and Washington Hospital Healthcare System.
Dr. Lee is part of our mission to offer patients the highest level of care
available anywhere. To further that goal, we have a strategic relationship
with UCSF Health and UCSF Benioff Children’s Hospitals. The focus
is to create a comprehensive and integrated regional health care network.
This includes providing Tri-City residents local access to many of UCSF’s
renowned specialty services, including cardiothoracic services, and providing
expanded access to these specialized physicians.
Prior to UCSF, Dr. Lee was co-director of the Aorta Center at University
of Florida. He also founded the Center for Aortic Disease at University
of Maryland and also started the highly successful Transcatheter Aortic
Valve (TAVR) program there.
Originally from Singapore, he graduated from Washington University School
of Medicine in St. Louis, MO. He then went on to a general surgery residency
at Case Western Reserve University in Cleveland, where he was also the
Dudley P. Allen Scholar before finishing his cardiothoracic surgery residency
at Duke University.
He also completed a fellowship in Endovascular/Interventional Radiology
at Skåne University Hospital (Lund University) in Malmö, Sweden
where he trained under the world-renowned Krassi Ivancev, M.D., Ph.D.
and another fellowship in advanced aortic surgery, heart transplantation,
and mechanical circulatory support at Duke University. Dr. Lee is one
of only a handful of "hybrid" specialists fully cross-trained
in both interventional and open surgical techniques for the treatment
of complex thoracic aortic disease.
Dr. Lee, who speaks English, Mandarin and Taiwanese, is a widely published
author of peer-reviewed research. He has a special interest in the development
of next-generation stent-graft technology, along with outcomes and management
of aortic dissection.